RLFTFRELIEF THERAPEUTICS HLDG AG

About RELIEF THERAPEUTICS HLDG AG (RLFTF)

RELIEF THERAPEUTICS HLDG AG (RLFTF) is a Biotechnology company headquartered in Geneva, Switzerland whose shares trade over-the-counter on the OTCQB tier.

Relief is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of novel, patent-protected products intended for the treatment of rare and ultra-rare diseases including dermatologic disorders, metabolic disorders, and pulmonary diseases. The parent company of the group, RELIEF THERAPEUTICS Holding SA, is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY.

Products and services

Relief is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of novel, patent protected products intended for the treatment of rare and ultra-rare diseases including metabolic disorders, pulmonary diseases, and connective tissue disorders.

RLFTF key facts

Ticker symbol

RLFTF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Geneva, Switzerland

Country of incorporation

CH

Year of incorporation

2013

Employees

36

Estimated market cap

$34.49M (as of Apr 10, 2025)

Shares outstanding

12,540,439

Reporting standard

International Reporting: SIX Swiss Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

RELIEF THERAPEUTICS HLDG AG leadership

• Jeremy Meinen — CFO
• Giorgio Reiner — Chief Scientific Officer
• Paolo Galfetti — CBO
• Vincenzo Gallo — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with R